- Home
- SVCO vs BIOA Comparison
SVCO vs BIOA Comparison
Compare SVCO & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVCO
- BIOA
- Stock Information
- Founded
- SVCO 1984
- BIOA 2015
- Country
- SVCO United States
- BIOA United States
- Employees
- SVCO N/A
- BIOA N/A
- Industry
- SVCO
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- SVCO
- BIOA Health Care
- Exchange
- SVCO NYSE
- BIOA Nasdaq
- Market Cap
- SVCO 140.5M
- BIOA 155.6M
- IPO Year
- SVCO 2024
- BIOA 2024
- Fundamental
- Price
- SVCO $5.00
- BIOA $4.15
- Analyst Decision
- SVCO Strong Buy
- BIOA Hold
- Analyst Count
- SVCO 5
- BIOA 4
- Target Price
- SVCO $17.00
- BIOA $5.67
- AVG Volume (30 Days)
- SVCO 96.8K
- BIOA 460.8K
- Earning Date
- SVCO 08-06-2025
- BIOA 08-15-2025
- Dividend Yield
- SVCO N/A
- BIOA N/A
- EPS Growth
- SVCO N/A
- BIOA N/A
- EPS
- SVCO N/A
- BIOA N/A
- Revenue
- SVCO $57,883,000.00
- BIOA $1,451,000.00
- Revenue This Year
- SVCO $14.25
- BIOA N/A
- Revenue Next Year
- SVCO $15.85
- BIOA N/A
- P/E Ratio
- SVCO N/A
- BIOA N/A
- Revenue Growth
- SVCO 3.65
- BIOA N/A
- 52 Week Low
- SVCO $3.55
- BIOA $2.88
- 52 Week High
- SVCO $20.69
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- SVCO N/A
- BIOA N/A
- Support Level
- SVCO N/A
- BIOA N/A
- Resistance Level
- SVCO N/A
- BIOA N/A
- Average True Range (ATR)
- SVCO 0.00
- BIOA 0.00
- MACD
- SVCO 0.00
- BIOA 0.00
- Stochastic Oscillator
- SVCO 0.00
- BIOA 0.00
About SVCO SILVACO GROUP INC
Silvaco Group Inc is a provider of technology computer aided design (TCAD) software, electronic data automation (EDA) software and semiconductor intellectual property (SIP). TCAD, EDA and SIP solutions enable semiconductor and photonics companies to increase productivity, accelerate their products' time-to-market and reduce their development and manufacturing costs. It is developing the technology behind the chip and providing solutions that span from atoms to systems, starting with providing software for the atomic level simulation of semiconductor and photonics material for devices, to providing software and SIP for the design and analysis of circuits and system level solutions.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.